RB1 and urogenital neoplasm: In urogenital cancer, Wu et al. have observed a significant co-occurrence of mutations between the TERT promoter and the tumor protein 51/retinoblastoma1 (TP53/RB1) signaling pathway, indicating that they may cooperatively contribute to the genesis and progression of bladder cancer48.